Mrna Vaccine

India's first homegrown mRNA vaccine likely to begin trials on humans in Feb, say sources

Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon, the official sources said

Moderna has begun human trials for an mRNA vaccine that targets multiple influenza strains

The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial to evaluate the safety and strength of immune response to the shot, called mRNA-1010.

India okays Moderna vaccine for emergency use: How does it work and how effective is it?

Moderna vaccine: The Moderna jab was the second vaccine to get an emergency nod in the US after the Pfizer vaccine, another mRNA shot

CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy

Franz-Werner Haas, chief executive blamed the results on the high number of variants in the countries where the vaccine was tested.

Hyderabad-based Biological E to manufacture Canadian firm Providence's COVID 19 vaccine

Biological E will conduct a bridging trial for the vaccine in India and also manufacture the vaccine.

Life-threatening allergic reaction to mRNA COVID-19 vaccination is rare, limited study suggests

People who got an anaphylactic episode following an mRNA vaccine dose usually had a history of allergy, or a previous instance of anaphylaxis.

As more COVID-19 vaccines get approval, experts debate if it's time for trial volunteers to get the real thing

In an ideal world, vaccine trial participants could hold off to discover whether they received the dummy shot or the vaccine. But experts agree the current circumstances are extraordinary

COVID-19 Vaccine Update: Moderna vaccine initial test results hailed in media, but experts are skeptical

On May 18, Moderna Inc announced that the preliminary results from the phase 1 trials of their mRNA-based COVID-19 vaccine seem to be promising.